文献速递功能神经外科

复发性或持续性三叉神经痛重复微血管减压术的系统综述

A Systematic Review of Repeat Microvascular Decompression for Recurrent or Persistent Trigeminal Neuralgia.
PubMed 文献 · World Neurosurg · 2021-12-05

该系统综述检索MEDLINE和PubMed至2020年7月,纳入19项临床研究,共2247例因三叉神经痛行微血管减压术的患者,其中311例复发(13.84%),178例接受重复微血管减压术;重复手术有效率为91.66%,术后并发症发生率为37.31%,作者认为重复微血管减压术仍是复发或持续性三叉神经痛的可行治疗。

要点

  • 2247例微血管减压术患者中311例复发,复发率13.84%,其中178例接受重复微血管减压术。
  • 重复微血管减压术有效率为91.66%,71.48%的患者术中可见明显压迫。
  • 重复微血管减压术后并发症发生率为37.31%,最常见为面部麻木(21.89%)。

核心结论

  • 对于微血管减压术后复发或持续性疼痛的患者,本系统综述结果支持重复微血管减压术仍是复发或持续性三叉神经痛的可行治疗。

研究设计与样本

  • 系统综述,检索MEDLINE和PubMed数据库至2020年7月,检索词包括复发性三叉神经痛、持续性三叉神经痛、重复微血管减压术和再探查。
  • 纳入标准为临床研究(排除病例研究)、重复微血管减压术治疗三叉神经痛、并记录疼痛缓解结局、术中发现和并发症(如有)的研究。
  • 初检获得1771条结果,对43项研究进行全文筛选,最终19项符合纳入标准。

主要发现

  • 共2247例患者因三叉神经痛行微血管减压术,其中311例复发(13.84%)。
  • 311例复发患者中178例接受重复微血管减压术,首次微血管减压术后平均无痛间期为27.75个月。
  • 重复微血管减压术有效率为91.66%,71.48%的患者在重复手术中发现明显压迫。
  • 重复微血管减压术后并发症发生率为37.31%,原因为术后神经周围粘连和部分感觉神经根切断术导致的神经损伤。
  • 重复微血管减压术后最常见并发症为面部麻木(21.89%),其他并发症发生率均低于5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: When conservative therapy fails, microvascular decompression (MVD) has been the preferred treatment of primary trigeminal neuralgia (TN). However, the management of recurrent or persistent TN after MVD can often be difficult. The purpose of the present systematic review was to objectively analyze and summarize the reported literature regarding the feasibility of repeat MVD. METHODS: We conducted a database search using the MEDLINE and PubMed databases until July 2020. The search terms used for title and abstract screening were as follows: "recurrent trigeminal neuralgia," "persistent trigeminal neuralgia," "repeat microvascular decompression," and "reexploration." The inclusion criteria for the systematic review were as follows: clinical studies (excluding case studies), repeat MVD treatment of TN, and studies that had recorded the pain relief outcomes, operative findings, and complications (if any). RESULTS: Of the 1771 initial results obtained, we performed a full text screening of 43 studies, and, ultimately, 19 were deemed eligible. A total of 2247 patients had undergone MVD for TN, of whom, 311 had experienced recurrence (13.84%). Of the 311 patients, 178 had undergone repeat MVD. The average pain-free interval was 27.75 months after the first MVD. The effective rate of repeat MVD was 91.66%, and 71.48% of the patients had had obvious compression found at repeat MVD. The postoperative complication rate after repeat MVD was 37.31% and was due to postoperative adhesions around the nerve and nerve injury caused by partial sensory rhizotomy. The most common complication after repeat MVD was facial numbness (21.89%), although the incidence of other complications was <5%. CONCLUSIONS: For patients with recurrent or persistent pain after MVD, the findings from our systematic review support that repeat MVD remains a feasible treatment for recurrent or persistent TN.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Jiao L, Ye H, Lv J, et al. A Systematic Review of Repeat Microvascular Decompression for Recurrent or Persistent Trigeminal Neuralgia. World Neurosurg. 2021. PMID: 34875391. doi:10.1016/j.wneu.2021.11.129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。